Press Release - October 24, 2024
Ceres Nanosciences Launches Nanotrap Protein Enrichment Affinity Kits
MANASSAS, Virginia – October 24, 2024 – Today, Ceres Nanosciences (Ceres) announced the launch of the Nanotrap® Protein Enrichment Affinity Kit (PEAK), a new product that uses the Nanotrap hydrogel particle technology to capture and concentrate low abundance, low molecular weight proteins and peptides while simultaneously excluding higher molecular weight proteins.
This product launch coincides with a talk at the Biomarkers US 2024 conference, titled “Leveraging ultra-deep proteomes to facilitate network-informed biomarker discovery for precision medicine,” in which a Director of Global Proteomics at a pharmaceutical company presents results demonstrating that the Nanotrap PEAK significantly increases the depth of proteome profiling in plasma and cerebrospinal fluid.
Nanotrap Protein Enrichment Affinity Kits have three different Nanotrap® Protein Particle chemistries offering unique protein binding profiles. They can be used individually or in combination to enhance the detection of low-abundance proteins and peptides from plasma samples, all with a simple 30-minute enrichment step prior to protein digestion. Each Nanotrap Protein Enrichment Affinity Kit is compatible with serum, plasma, cerebrospinal fluid, or urine samples and integrates seamlessly with a wide range of downstream protein digestion methods.
“We understand that researchers need robust protein enrichment tools that deliver deep proteome insights without adding complexity to their workflows,” said Ben Lepene, Chief Technology Officer at Ceres Nanosciences. “That is why we’re thrilled to introduce the Nanotrap Protein Enrichment Affinity Kits, which are simple, versatile, and seamlessly fit into any proteomics pipeline.”
Additional product information, including protocols and application notes are available at www.ceresnano.com/nanotrap-peak.
###
About Ceres Nanosciences, Inc.
Ceres Nanosciences is a privately held company, located in Prince William County, Virginia, focused on incorporating its novel Nanotrap® particle technology into a range of diagnostic and research products and workflows. The Nanotrap® particle technology can improve diagnostic testing by capturing, concentrating, and preserving low abundance analytes from biological samples. The Nanotrap® particle technology was developed with support from the National Institutes of Health, the Defense Advanced Research Projects Agency, the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency, and the Virginia Catalyst Program. Learn more, including how Ceres is partnering with leading life science, bio-pharmaceutical, and diagnostic companies at www.ceresnano.com.
Press Contact:
Ross M. Dunlap
Ceres Nanosciences, Inc
1.800.615.0418 ext. 202